Medical Devices Reimbursement Market Size & Growth Forecast 2027–2036, By Segments (Claims, Application, Service Provider), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Medical Devices Reimbursement Market size was estimated at USD 891.7 billion in 2026 and is projected to grow at a 7.51% CAGR from 2027 to 2036, surpassing USD 1.84 trillion by 2036. The industry revenue for 2027 is calculated at USD 948.06 billion.
Get more details on this report
Request Free Sample ReportMedical Devices Reimbursement Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 48.45% share due to mature reimbursement systems, broad insurance coverage, and structured coding pathways enabling high device adoption across care settings.
- Asia Pacific is growing at 10.17% CAGR due to expanding healthcare access, deeper insurance penetration, and rising adoption of advanced medical devices across evolving care systems.
Segment Momentum
- Underpaid claims held a 77.18% share in 2026 because identifying and recovering missed revenue from partially reimbursed claims requires specialized review processes, creating sustained demand for reimbursement management services.
- Private Payers are the fastest-growing segment as varying commercial plan policies, coverage conditions, and payment outcomes increase the need for specialized claims expertise and revenue recovery support.
Market Expansion Drivers
- Rising prevalence of chronic diseases increasing reimbursement demand for advanced medical devices.
- Transition toward value-based healthcare models strengthening outcome-driven reimbursement frameworks.
- Expanding government healthcare coverage initiatives improving patient access to reimbursable medical technologies.
Leading Market Participants
- Top players in the medical devices reimbursement market include IQVIA Holdings Inc. (United States), Humana Inc. (United States), The Cigna Group (United States), Elevance Health, Inc. (United States), Abbott Laboratories (United States), Boston Scientific Corporation (United States), Johnson & Johnson (United States), UnitedHealth Group Incorporated (United States), Medtronic plc (Ireland), AdvaMed (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 891.7 billion
- 2027 Estimated Market Size: USD 948.06 billion.
- Projected Market Size: USD 1.84 trillion by 2036
- Growth Forecast: 7.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Underpaid (Claims) | Public Payers (Application) | Physician Office (Service Provider)
- Emerging Opportunity Segment: Underpaid (Claims) | Private Payers (Application) | Hospitals (Service Provider)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic diseases increasing reimbursement demand for advanced medical devices
The growing burden of chronic diseases is increasing the need for continuous diagnosis, monitoring, treatment, and long-term disease management, creating greater demand for medical technologies supported by reimbursement mechanisms. The medical devices reimbursement market is expanding as patients and healthcare providers increasingly rely on advanced devices for managing cardiovascular, metabolic, respiratory, neurological, and other chronic conditions. Reimbursable access can reduce the financial barriers associated with specialized equipment and enable broader use of devices that support disease monitoring and therapeutic interventions. Increasing clinical reliance on technology-enabled care is also strengthening the importance of reimbursement pathways for advanced medical devices.
Transition toward value-based healthcare models strengthening outcome-driven reimbursement frameworks
Healthcare systems are increasingly emphasizing treatment outcomes, quality of care, and efficient resource utilization rather than relying solely on the volume of services delivered. This transition is shaping the medical devices reimbursement market by encouraging reimbursement approaches that consider the clinical and economic value generated by medical technologies. Device manufacturers and healthcare providers are therefore placing greater emphasis on demonstrating improvements in patient outcomes, reducing complications, and supporting efficient care delivery. Reimbursement frameworks linked to measurable performance can also encourage adoption of devices that contribute to better disease management and more efficient healthcare pathways.
Expanding government healthcare coverage initiatives improving patient access to reimbursable medical technologies
Government efforts to broaden healthcare coverage are increasing opportunities for patients to obtain medical devices through public reimbursement programs and expanded benefits. The medical devices reimbursement market will benefit as policymakers seek to improve access to essential diagnostic, monitoring, and therapeutic technologies across different patient populations. Wider coverage can reduce out-of-pocket costs and make advanced devices more accessible to individuals who may otherwise delay or avoid treatment because of affordability constraints. Expansion of public healthcare programs also encourages providers to incorporate reimbursable technologies into routine clinical pathways where coverage criteria are met.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic diseases increasing reimbursement demand for advanced medical devices | 2.20% | High | North America, Europe | High | Near Term |
| Transition toward value-based healthcare models strengthening outcome-driven reimbursement frameworks | 1.90% | High | North America, Asia Pacific | High | Mid Term |
| Expanding government healthcare coverage initiatives improving patient access to reimbursable medical technologies | 1.60% | High | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the medical devices reimbursement market at 48.45% in 2026, supported by sophisticated healthcare systems, extensive use of advanced medical technologies, and established reimbursement frameworks. Strong demand for diagnostic, therapeutic, and implantable devices is reinforced by high healthcare utilization and the presence of well-developed public and private coverage mechanisms. Ongoing efforts to improve healthcare outcomes and expand access to innovative medical technologies are also supporting reimbursement activity, while evolving payment models increasingly emphasize clinical value, cost effectiveness, and patient outcomes.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing region, driven by expanding healthcare infrastructure, increasing medical device adoption, and efforts to broaden access to modern healthcare services. Rising healthcare expenditure and improving hospital capabilities are creating greater demand for sophisticated medical technologies, increasing the importance of effective reimbursement mechanisms. Governments and healthcare systems are also working to strengthen coverage and improve affordability, while growing awareness of advanced treatment options is encouraging wider utilization of medical devices across both developed and emerging markets in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Evidence-Driven EvaluationGermany prioritizes structured reimbursement pathways supported by clinical validation and health technology assessment. Medical device companies operating in Germany focus on generating robust evidence that supports reimbursement decisions and integration into routine healthcare practice.
France 🇫🇷
Healthcare Access PrioritiesFrance emphasizes reimbursement policies that encourage patient access while maintaining rigorous evaluation of medical device effectiveness. Medical technology companies in France invest in clinical and economic evidence to support sustainable reimbursement decisions across healthcare settings.
Italy 🇮🇹
Regional Reimbursement CoordinationItaly's medical devices reimbursement market reflects the importance of coordinating national policy with regional healthcare implementation. Medical device suppliers in Italy focus on demonstrating clinical utility and budget impact to support broader procurement and reimbursement acceptance.
Japan 🇯🇵
Clinical Adoption AlignmentJapan advances the medical devices reimbursement market by closely linking reimbursement decisions with clinical effectiveness and healthcare quality objectives. Companies in Japan emphasize regulatory coordination and evidence generation to facilitate broader hospital adoption.
South Korea 🇰🇷
Digital Healthcare IntegrationSouth Korea increasingly incorporates reimbursement approaches that accommodate innovative medical technologies and digital healthcare solutions. Medical device suppliers in South Korea focus on demonstrating clinical value while adapting to evolving reimbursement frameworks across healthcare providers.
United States 🇺🇸
Value-Based Coverage ModelsThe U.S. medical devices reimbursement market places strong emphasis on clinical evidence, healthcare outcomes, and payer acceptance. Medical device manufacturers in the U.S. increasingly align reimbursement strategies with demonstrated patient benefits and cost-effective healthcare delivery.
Segment Leadership and Growth Trends
Medical Devices Reimbursement Market Share (%), by Claims, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportClaims Segment Analysis: Underpaid (Largest & Fastest-Growing Segment)
The underpaid claims segment accounted for the largest and fastest-growing share of the medical devices reimbursement market, representing 77.18% in 2026. Underpayment of medical device claims creates a significant reimbursement management requirement as healthcare providers and suppliers seek to recover amounts that do not adequately reflect eligible payments for devices and associated services. Increasing complexity in reimbursement policies, claim adjudication, coding, and payer-provider interactions can contribute to payment discrepancies, making identification and resolution of underpaid claims an important component of revenue-cycle management. Greater use of automated claims analysis and specialized reimbursement processes is further supporting demand for solutions focused on detecting payment shortfalls and improving reimbursement accuracy.
Application Segment Analysis: Public Payers (Largest Segment) vs Private Payers (Fastest-Growing Segment)
Public payers led the medical devices reimbursement market with a 64.31% share in 2026, supported by their extensive role in financing medical care and reimbursing devices across broad patient populations. Public reimbursement systems involve complex eligibility requirements, coverage policies, coding procedures, and payment rules, creating substantial demand for accurate claims processing and reimbursement oversight. The need to manage large volumes of medical device claims while maintaining compliance with established reimbursement frameworks continues to reinforce the importance of public payers within the market.
Private payers are expanding at a faster pace as healthcare financing becomes increasingly focused on efficient claims administration, cost control, and accurate reimbursement for advanced medical technologies. Private insurers face growing pressure to evaluate device-related claims against coverage terms and negotiated payment arrangements while maintaining efficient relationships with providers. Greater adoption of digital claims processing and analytics is helping private payers identify discrepancies and improve reimbursement management.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Claims | Underpaid, Full Paid | Underpaid | Underpaid |
| Application | Public Payers, Private Payers | Public Payers | Private Payers |
| Service Provider | Physician Office, Hospitals, Diagnostic Laboratories, Others | Physician Office | Hospitals |
Competitive Landscape and Market Positioning
Major players in the medical devices reimbursement market:
1. IQVIA Holdings Inc. (United States)
2. Humana Inc. (United States)
3. The Cigna Group (United States)
4. Elevance Health Inc. (United States)
5. Abbott Laboratories (United States)
6. Boston Scientific Corporation (United States)
7. Johnson & Johnson (United States)
8. UnitedHealth Group Incorporated (United States)
9. Medtronic plc (Ireland)
10. AdvaMed (United States)
The medical devices reimbursement market is witnessing increasing alignment with value-based healthcare frameworks aimed at improving treatment accessibility and patient outcomes. Stakeholders are refining reimbursement models to support innovative medical technologies while ensuring cost efficiency within healthcare systems. Growing emphasis on evidence-based approvals and streamlined claim management processes continues to influence market dynamics.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IQVIA Holdings Inc. (United States) | |||||||
| Humana Inc. (United States) | |||||||
| The Cigna Group (United States) | |||||||
| Elevance Health Inc. (United States) | |||||||
| Abbott Laboratories (United States) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Johnson & Johnson (United States) | |||||||
| UnitedHealth Group Incorporated (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| AdvaMed (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| UnitedHealth Group | Nov-25 | UnitedHealth Group launched structured outcomes-based reimbursement contracts for implantable cardiac defibrillators and cardiac resynchronization therapy devices. This initiative directly links manufacturer reimbursement payouts to real-world patient clinical outcomes, accelerating the transition toward value-based procurement models for high-cost cardiovascular technologies. |
| CVS Health | Sep-25 | CVS Health rolled out an integrated diabetes management infrastructure that combines continuous glucose monitor reimbursement with clinical pharmacy services and predictive analytics. This care model shifts reimbursement design toward comprehensive digital health ecosystems, streamlining coverage and utilization management for continuous monitoring devices. |
| Centers for Medicare & Medicaid Services | Aug-25 | The Centers for Medicare & Medicaid Services issued a National Coverage Determination establishing reimbursement for Implantable Pulmonary Artery Pressure Sensors under the Coverage with Evidence Development framework. This regulatory decision formally approves the CardioMEMS study, expanding uniform coverage and medical device access to all qualified Medicare beneficiaries. |
| French National Authority for Health | Feb-25 | The French National Authority for Health, via its specialized evaluation commission, issued seven structural recommendations regarding add-on device coverage within the national List of Reimbursable Products and Services. The framework updates clinical evaluation methodologies and pricing structures across multiple device sectors, directly impacting national market entry. |
| Optum | Jun-23 | Optum executed a strategic partnership with high-acuity and home health provider Amedisys to integrate clinical delivery with lower-cost care settings. The consolidation expands Optum's operational footprint in home-based medical care, directly driving the utilization and cost-management structures of medical devices within home health networks. |
| Humana | May-23 | Humana established regional value-based procurement partnerships with national durable medical equipment providers AdaptHealth Corp. and Rotech Healthcare Inc. This structural realignment optimizes the device distribution network and acquisition lifecycle for Medicare Advantage members, migrating equipment reimbursement away from fee-for-service frameworks. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Medical Devices Reimbursement Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Device Category | Diagnostic Devices, Therapeutic Devices, Monitoring Devices, Surgical Devices |
| Reimbursement Pathway | Medicare & Government Programs, Commercial Insurance, Employer-Sponsored Plans, Self-Pay & Other Reimbursement |
| Procedure Type | Inpatient Procedures, Outpatient Procedures, Ambulatory Procedures, Office-Based Procedures |
Medical Devices Reimbursement Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Reimbursement Pathway Benchmarking |
|
| Payer Coverage Strategy Assessment |
|
| Value-Based Healthcare Adoption Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow big is the medical devices reimbursement market?
How is the medical devices reimbursement industry expected to grow over the next 10 years?
How are value-based healthcare models influencing the medical devices reimbursement market?
Why is expanding healthcare coverage driving growth in the medical devices reimbursement market?
Why do underpaid claims dominate the medical devices reimbursement market?
What is accelerating growth in private payer reimbursement activities?
Why does North America lead the medical devices reimbursement market?
What is driving Asia Pacific’s fastest growth in medical devices reimbursement?
Who are the major participants shaping the medical devices reimbursement landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization